Harvard University, Joslin Diabetes Center — Boston, Massachusetts

Harvard University, Joslin Diabetes Center is a clinical research site located in Boston, Massachusetts, United States 002215.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Harvard University, Joslin Diabetes Center has participated in 1 clinical trials.

Therapeutic areas: Type 1 Diabetes Mellitus, New-onset Type 1 Diabetes Mellitus, T1DM.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Harvard University, Joslin Diabetes Center?

Harvard University, Joslin Diabetes Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Harvard University, Joslin Diabetes Center conducted?

Harvard University, Joslin Diabetes Center has 1 clinical trials on record. Their work covers Type 1 Diabetes Mellitus, New-onset Type 1 Diabetes Mellitus, T1DM.

Is Harvard University, Joslin Diabetes Center accredited by Crixeo Health?

Harvard University, Joslin Diabetes Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Harvard University, Joslin Diabetes Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.